関連する実験動画
Updated: Jun 28, 2026

05:57
Fat Preference: A Novel Model of Eating Behavior in Rats
Published on: June 27, 2014
肥満と食品に対する鈍化したストライタル応答の間の関係は,TaqIA A1アレルによって調節されます
1Oregon Research Institute, 1715 Franklin Boulevard, Eugene, OR 97403, USA. estice@ori.org .
まとめ
背面のストライアタム活性化が低下した個人は,特にドーパミンのシグナル伝達に影響を与える遺伝的要因を有する個人は,過食することがあります. この脳の領域は,
科学分野:
- 神経科学は神経科学である.
- 肥満に関する研究
- 遺伝学 遺伝学とは
背景:
- 背面のストライアタムは,食物 (報酬) の処理に不可欠です.
- 肥満の個人は,ストライアトゥームのドーパミンD2受容体が減少しています.
- これは,線状ドーパミンシグナル伝達と肥満の発症の間の関連性を示唆しています.
研究 の 目的:
- 食物摂取時の背面のストライアタム活性化と体量との関係を調査する.
- 遺伝的変異 (TaqIAポリモルフィズム) がこの関係を緩和するかどうかを調べる.
- 肥満におけるドーパミンD2受容体 (DRD2) 遺伝子の役割を調査する.
主な方法:
- 2つの研究で機能的磁気共鳴画像 (fMRI) を利用しました.
- 分析された横断データと展望データ.
- 食品摂取に対する反応として評価されたストライタル活性化.
主要な成果:
- 食事の摂取中の状管の活性化は,現在の体量と相関しています.
- ストライタル・アクティベーションの減少は,将来の体量増加を予測した.
- TaqIAポリモルフィズムのA1アレルは,これらの関連を緩和した.
結論:
- 機能不全の背筋帯体は,補償として過食を誘発する可能性があります.
- ドーパミンのシグナル伝達に影響する遺伝的ポリモルフィズムはこの効果を悪化させる.
- 発見は,肥満の病原性におけるストライアタル機能とDRD2遺伝子を意味しています.
関連する概念動画
Human Genetics
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
Regulation of Food Intake
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
